Diepgen, T. L., Eicke, C., & Bastian, M. (2019). Ingenol mebutate as topical treatment for actinic keratosis based on a prospective, non-interventional, multicentre study of real-life clinical practice in Germany: Efficacy and quality of life. European journal of dermatology, 29(4), . https://doi.org/10.1684/ejd.2019.3603
Chicago-Zitierstil (17. Ausg.)Diepgen, Thomas L., Christoph Eicke, und Mike Bastian. "Ingenol Mebutate as Topical Treatment for Actinic Keratosis Based on a Prospective, Non-interventional, Multicentre Study of Real-life Clinical Practice in Germany: Efficacy and Quality of Life." European Journal of Dermatology 29, no. 4 (2019). https://doi.org/10.1684/ejd.2019.3603.
MLA-Zitierstil (9. Ausg.)Diepgen, Thomas L., et al. "Ingenol Mebutate as Topical Treatment for Actinic Keratosis Based on a Prospective, Non-interventional, Multicentre Study of Real-life Clinical Practice in Germany: Efficacy and Quality of Life." European Journal of Dermatology, vol. 29, no. 4, 2019, https://doi.org/10.1684/ejd.2019.3603.